Evidence map›Paper›PMID 36806980›Full record

Observational studyCerebellum (London, England)2024

Cerebellar Cognitive Affective Syndrome in Mexican Pediatric Patients with Ataxia-Telangiectasia.

Elizabeth Alejandra De la Cruz Córdoba, Juan Antonio González Medrano, Patricia Herrera Mora, Gilberto Gómez-Garza, María Edith González-Serrano, Marco Antonio Yamazaki-Nakashimada, Carmen Alicia Correa-Ramírez

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Cerebellum (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Elizabeth Alejandra De la Cruz CórdobaNeurological Rehabilitation, Autonomous Metropolitan University, Calz. Del Hueso 1100, Col Villa Quietud, Coyoacan, 04960, Mexico City, Mexico.
Juan Antonio González MedranoNeurological Rehabilitation, Autonomous Metropolitan University, Calz. Del Hueso 1100, Col Villa Quietud, Coyoacan, 04960, Mexico City, Mexico.
Patricia Herrera MoraDepartment of Neurology, National Institute of Pediatrics, Av. Insurgentes Sur 3700-C. Col Insurgentes Cuicuilco, Coyoacan, 04530, Mexico City, Mexico.
Gilberto Gómez-GarzaDepartment of Radiology and Imaging, National Institute of Pediatrics, Av. Insurgentes Sur 3700-C, Col Insurgentes Cuicuilco, Coyoacan, 04530, Mexico City, Mexico.
María Edith González-SerranoPrimary Immunodeficiencies Laboratory, National Institute of Pediatrics, Av. Insurgentes Sur 3700-C, Col Insurgentes Cuicuilco, Coyoacan, 04530, Mexico City, Mexico.
Marco Antonio Yamazaki-NakashimadaDepartment of Clinical Immunology, National Institute of Pediatrics, Av. Insurgentes Sur 3700-C, Col Insurgentes Cuicuilco, Coyoacan, 04530, Mexico City, Mexico.
Carmen Alicia Correa-RamírezNeurodevelopment Research Center, National Institute of Pediatrics, Av. Insurgentes Sur 3700-C, Col Insurgentes Cuicuilco, Coyoacan, 04530, Mexico City, Mexico. escor97@hotmail.com.
Universidad Insurgentes · MXUniversidad Autónoma Metropolitana · MX

Funding

Consejo Nacional de Ciencia y Tecnología 724243
6 · The paper itself

Abstract

Ataxia-telangiectasia (A-T) is a disease caused by mutations in the ATM gene (11q22.3-23.1) that induce neurodegeneration Sasihuseyinoglu AS et al.  Pediatr Allergy Immunol Pulmonol 31(1):9-14, 2018, Teive HAG et al. Parkinsonism Relat Disord 46:3-8, 2018. Clinically, A-T is characterized by ataxia, mucocutaneous telangiectasia, immunodeficiency, and malignancy. Movement disorders have been the most described and well-studied symptoms of A-T. Other studies have reported visuospatial processing disorders, executive function disorders and emotional regulation disorders, which are clinical manifestations that characterize cerebellar cognitive affective syndrome (CCAS) Choy KR et al. Dev Dyn 247(1):33-46, 2018. To describe the neurocognitive and emotional state of pediatric patients with ataxia-telangiectasia and to discuss whether they have cerebellar cognitive affective syndrome. This observational, cross-sectional, and descriptive study included 9 patients with A-T from May 2019 to May 2021. A complete medical history was retrieved, and tests were applied to assess executive functions, visual-motor integration and abilities, language, psychological disorders, and ataxia. Six girls and 3 boys agreed to participate. The age range was 6 to 14 years. The participants included five schoolchildren and four teenagers. Eight patients presented impaired executive functioning. All patients showed some type of error in copying and tracing (distortion) in the performance of visual perceptual abilities. Emotional disorders such as anxiety and depression were observed in six patients. Eight patients presented with dyslalia and impairments in word articulation, all patients presented with ataxia, and seven patients used a wheelchair. All patients presented symptoms consistent with CCAS and had variable cognitive performance.

Indexed as

Ataxia TelangiectasiaCerebellar AtaxiaCerebellar DiseasesAdolescentChildCognitionCross-Sectional StudiesFemaleHumansMaleAtaxia-telangiectasiaCerebellar cognitive affective syndromeCerebellumExecutive functions

Identifiers

PMID36806980
OpenAlexW4321435816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.